Two Drug Molecules Discovered at University of Montpellier

Macrilen (Macimorelin): CAS [381231-18-1], FDA-approved (December 2017) used to diagnose growth hormone deficiency. Professor Jean Martinez's Lab. Sebivo in Europe, Tyzeka in USA, (Telbivudine), CAS [3424-98-4], FDA-approved (October 2006), is an antiviral drug used in the treatment of hepatitis B infection. Professors Jean-louis Imbach and Gilles Gosselin's Lab. Obefazimod, CAS [1258453-75-6], Phase III completed, is an investigational new drug that is being evaluated for the treatment of ulcerative colitis. Professor Jamal Tazi's Lab.